Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRDN · against 359 other Healthcare companies of similar size
Ranked #185 of 360 · scores higher than 48% of peers
Bars: peers in each 10-point band of the valuation score32 peers with a valuation score of 50–59, including GRDN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | GRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 351 reported | 2.5% | 2.3% | 52% | 30% | |
| EBITDA yieldHigher is better · 357 reported | 4.3% | 4.6% | 48% | 50% | |
| Free cash flow yieldHigher is better · 179 reported | 3.1% | -0.1% | 65% | 20% | |
| Book yieldHigher is better · 351 reported | 9.5% | 32.5% | 13% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 181 | 1.6B USD | 55 | 51 | |
| 181 | 3.0B USD | 55 | 39 | |
| 185 | 10.0B CNY (≈$1.4B) | 53 | 58 | |
| 185 | 21.5B DKK (≈$3.2B) | 53 | 58 | |
| 185 | 2.6B USD | 53 | 66 | |
| 185 | 1.5B USD | 53 | 59 | |
| 185 | 1.6B USD | 53 | 48 | |
| 190 | 10.6B CNY (≈$1.5B) | 52 | 43 | |
| 190 | 1.4B USD | 52 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score